FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel Rejects Correvios Vernakalant Over Safety

[ Price : $8.95]

FDAs Cardiovascular and Renal Drug Advisory Committee votes 11-2 against recommending approval of Correvio Pharmas vernakalant for...

Sozo Cleared for Assessing Protein Calorie Malnutrition

[ Price : $8.95]

FDA clears an ImpediMed 510(k) for Sozo, intended for use as an aid in assessing protein calorie malnutrition.

Vabomeres Regulatory Review Period Determined

[ Price : $8.95]

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Rempex Pharmaceuticals Vabo...

Info Collection on Minor Use/Species Drugs

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension for Reporting Associated With Designated New Animal ...

CGMP Violations Found in Teligent Inspection

[ Price : $8.95]

FDA warns Teligent Pharma about CGMP and Field Alert Report violations in its manufacturing of finished pharmaceuticals.

OHM Inspection Finds CGMP Issues

[ Price : $8.95]

FDA warns OHM Pharma about CGMP and other violations in its manufacturing of finished pharmaceuticals.

OrthoGrid Systems PhantomMSK Trauma Cleared

[ Price : $8.95]

FDA clears an OrthoGrid Systems 510(k) for its application PhantomMSK Trauma for use in orthopedic surgery.

Advance Notice, Staffing Still Harm Foreign Inspections: GAO

[ Price : $8.95]

New Government Accountability Office findings on FDAs foreign inspection program acknowledge improvements pointing up persistent r...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes OHM Pharma and Teligent Pharma.

Alert on Recalled Products from Basic Reset/Biogenyx

[ Price : $8.95]

FDA says 25 unapproved drug, dietary supplement and medical device product lines distributed by Basic Reset and Biogenyx, have bee...